“Socio-Gerontological Perspectives on Disease-Modifying Alzheimer’s Therapies (Lecanemab): A Delphi Study in Central Europe”, J. Heal. Rehab. Sci., vol. 5, no. 1, pp. 8–16, Jun. 2026, doi: 10.33700/jhrs.5.1.222.